Charles E. Seiler

596 total citations
15 papers, 442 citations indexed

About

Charles E. Seiler is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Charles E. Seiler has authored 15 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Charles E. Seiler's work include Prion Diseases and Protein Misfolding (4 papers), Alzheimer's disease research and treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). Charles E. Seiler is often cited by papers focused on Prion Diseases and Protein Misfolding (4 papers), Alzheimer's disease research and treatments (3 papers) and Ubiquitin and proteasome pathways (3 papers). Charles E. Seiler collaborates with scholars based in United States, Italy and Germany. Charles E. Seiler's co-authors include Pedro Piccardo, Bernardino Ghetti, Fabrizio Tagliavini, Orso Bugiani, Frances Prelli, Giorgio Giaccone, Francesco Perini, Jun Tateishi, Tetsuyuki Kitamoto and Y Ichimiya and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Charles E. Seiler

14 papers receiving 435 citations

Peers

Countries citing papers authored by Charles E. Seiler

Since Specialization

Citations

This map shows the geographic impact of Charles E. Seiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Seiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Seiler more than expected).

Fields of papers citing papers by Charles E. Seiler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Seiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Seiler. The network helps show where Charles E. Seiler may publish in the future.

Co-authorship network of co-authors of Charles E. Seiler

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Seiler. A scholar is included among the top collaborators of Charles E. Seiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Seiler. Charles E. Seiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Vaccination for Invasive Canine Meningioma Induces In Situ Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity 2013 ·Cancer Research ·(unknown), G. Elizabeth Pluhar, Charles E. Seiler, Michelle R. Goulart, Karen S. SantaCruz, Melissa M. Schutten, (unknown), Maeve O’Sullivan, R. Timothy Bentley, Rebecca A. Packer, (unknown), Annie V. Chen, Dominik Faissler, Wei Chen, Matthew A. Hunt, Michael R. Olin, John R. Ohlfest	37
2	CD8+ T Cell–Independent Tumor Regression Induced by Fc-OX40L and Therapeutic Vaccination in a Mouse Model of Glioma 2013 ·The Journal of Immunology ·Katherine A. Murphy, Jami R. Erickson, Charles S. Johnson, Charles E. Seiler, (unknown), Peisheng Hu, G. Elizabeth Pluhar, Alan L. Epstein, John R. Ohlfest	19
3	Quantitative Proteomic Identification of Novel Diagnostic Biomarkers and Therapeutic Targets for Classical Hodgkin Lymphoma. 2008 ·Blood ·(unknown), Damian Fermin, Venkatesha Basrur, Kevin Conlon, Charles E. Seiler, Ian M. Waxman, Mitchell S. Cairo, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	0
4	Comprehensive identification of proteins in Hodgkin lymphoma-derived Reed–Sternberg cells by LC-MS/MS 2007 ·Laboratory Investigation ·(unknown), (unknown), Charles E. Seiler, Cecily P. Vaughn, David K. Crockett, Sheryl R. Tripp, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	18
5	Global proteome profiling of NPM/ALK-positive anaplastic large cell lymphoma 2007 ·Experimental Hematology ·(unknown), Charles E. Seiler, David K. Crockett, Sheryl R. Tripp, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	11
6	Aktueller Stand der Diagnostik und Therapie der Peritonitis 2007 ·Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie ·Hanns‐Peter Knaebel, Charles E. Seiler, Markus Weigand, M Büchler	1
7	Constitutive Activation of FRAP/mTOR Pathway in Pediatric Anaplastic Large Cell Lymphomas: Potential Role as a Therapeutic Target. 2006 ·Blood ·Megan S. Lim, Charles E. Seiler, Sheryl R. Tripp, Sherrie L. Perkins, Mitchell S. Cairo, Kojo S.J. Elenitoba‐Johnson	1
8	Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma – CapRI: study protocol [ISRCTN62866759] 2005 ·BMC Cancer ·HP Knaebel, Angela Märten, Jan Schmidt, Katrin Hoffmann, Charles E. Seiler, Katja Lindel, Hubertus Schmitz‐Winnenthal, Stefan Fritz, Thomas Herrmann, Hartmut Goldschmidt, R. Krempien, Ulrich Mansmann, Jürgen Debus, Volker Diehl, (unknown)	61
9	Annotated proteome of a human T-cell lymphoma. 2005 ·PubMed ·David K. Crockett, Charles E. Seiler, Kojo S.J. Elenitoba‐Johnson, Megan S. Lim	3
10	AN ANTISERUM TO RESIDUES 95–108 OF HUMAN PRP DETECTS PRPres IN A VARIETY OF HUMAN AND ANIMAL PRION DISEASES 1997 ·Journal of Neuropathology & Experimental Neurology ·Pedro Piccardo, Fabrizio Tagliavini, S. R. Dlouhy, Kevin G. Young, Charles E. Seiler, G. Rossi, Andrew F. Hill, Marianna Bugiani, (unknown), (unknown), Bernardino Ghetti	1
11	Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. 1996 ·Proceedings of the National Academy of Sciences ·Bernardino Ghetti, Pedro Piccardo, Maria Grazia Spillantini, Y Ichimiya, M. Porro, Francesco Perini, Tetsuyuki Kitamoto, Jun Tateishi, Charles E. Seiler, B Frangione, Orso Bugiani, Giorgio Giaccone, Frances Prelli, Michel Goedert, S. R. Dlouhy, Fabrizio Tagliavini	219
12	Proteinase-K-Resistant Prion Protein Isoforms in Gerstmann-Sträussler-Scheinker Disease (Indiana Kindred) 1996 ·Journal of Neuropathology & Experimental Neurology ·Pedro Piccardo, Charles E. Seiler, Stephen R. Dlouhy, Katherine Young, Martin R. Farlow, Frances Prelli, Blas Frangione, Orso Bugiani, Fabrizio Tagliavini, Bernardino Ghetti	42
13	Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles 1996 ·Bernardino Ghetti, Pedro Piccardo, M. G. Spillantini, Y Ichimiya, M. Porro, Francesca Perini, Tetsuyuki Kitamoto, J Tateishi, Charles E. Seiler, B Frangione, Orso Bugiani, Giorgio Giaccone, Frances Prelli, Michel Goedert, S. R. Dlouhy, Fabrizio Tagliavini	1
14	Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165 1995 ·Journal of Neuropathology & Experimental Neurology ·Pedro Piccardo, Bernardino Ghetti, Dennis W. Dickson, Harry V. Vinters, Orso Bugiani, Fabrizio Tagliavini, (unknown), Stephen R. Dlouhy, Charles E. Seiler, Carrie K. Jones, Alice Lazzarini, Lawrence I. Golbe, Thomas Zimmerman, Susan Perlman, (unknown), Peter St George‐Hyslop, (unknown), Giorgio Giaccone	25
15	lmmunohistochemical Detection of the Ca Antigen in Normal and Tumor Tissues of Humans by Use of Cal Monoclonal Antibody<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref> 1985 ·JNCI Journal of the National Cancer Institute ·C S Woodhouse, Charles E. Seiler, A C Morgan, R. K. Oldham	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact